Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of TCC Followed by MBCT and Predictive Factors (Genetic, Clinical and Cognitive) Response

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients aged 18-65 years~* Men and women~* Addressed to the CBT unit of the Clinique des Maladies Mentales et de l'Encéphale - CMME- (Sainte Anne Hospital)~* Having a bipolar I or II disorder (224 patients) or eating disorder (224 patients) : bulimia or discorder of use alcohol or gambling (224 patients)~* mood stabilizer treatment for more than six months, for bipolar patients~* Understanding and speaking French fluently~* Patient agreeing to participate and signing the consent form~Exclusion Criteria:~* Age \<18 or\> 65~* current manic, hypomanic, or depressive episode for bipolar patients~* Score on the Hamilton Depression Rating Scale - HDRS greater than or equal to 16~* Score on the Mania Rating Scale - MRS higher or equal to 6 for bipolar patients~* Schizophrenic disorder~* Severe somatic pathology (cancer, heart, kidney or respiratory failure, central neurological disorder), scalable, or are likely to be life-threatening in a period of less than one year~* Refusal of a mood stabilizer treatment for bipolar patients~* Inability to respond to assessment (eg failure or deterioration of mental ability.)~* No affiliation to a social security scheme~* Private topics of liberty by judicial or administrative decision~* Pregnant women~For bipolar patients, the presence of rapid cycling, family history of bipolar disorder, comorbid Axis I and II disorders, protective measures (curatorship or guardianship) are not exclusion criteria.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- bipolar disorder (Type: EXPERIMENTAL): Cognitive and Behavior Therapy (CBT) : 20-weeks CBT~+ Mindfulness Based Cognitive Therapy (MBCT) : 8-weeks MBCT
- anxious disorders (Type: EXPERIMENTAL): Cognitive and Behavior Therapy (CBT) : 20-weeks CBT~+ Mindfulness Based Cognitive Therapy (MBCT) : 8-weeks MBCT
- alcohol disorder (Type: EXPERIMENTAL): Cognitive and Behavior Therapy (CBT) : 20-weeks CBT~+ Mindfulness Based Cognitive Therapy (MBCT) : 8-weeks MBCT

Based on this trial design, predict the completion outcome and termination type (if applicable).